Tempest Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-26.0M | $-26.1M | $135.0K |
| FY2022 | $-31.1M | $-31.6M | $562.0K |
| FY2023 | $-27.4M | $-27.5M | $170.0K |
| FY2024 | $-33.0M | $-33.5M | $435.0K |
| FY2025 | $-26.8M | $-26.8M | $0 |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-26.0M | $-26.1M | $135.0K |
| FY2022 | $-31.1M | $-31.6M | $562.0K |
| FY2023 | $-27.4M | $-27.5M | $170.0K |
| FY2024 | $-33.0M | $-33.5M | $435.0K |
| FY2025 | $-26.8M | $-26.8M | $0 |